Compass Pathways (MEX:CMPSN) EBIT: MXN-3,257.36 Mil (TTM As of Mar. 2026)


MEX:CMPSN Compass Pathways PLC MEX:CMPSN
14 GF Score
Price MXN242.00
! 2 Warning Signs
View Full Analysis

What is Compass Pathways EBIT?

Compass Pathways MEX:CMPSN 14 EBIT is MXN-3,257.36 Mil as of Mar. 2026. GuruFocus rates MEX:CMPSN with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Compass Pathways's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was MXN1,670.84 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN-3,257.36 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Compass Pathways's annualized ROC % for the quarter that ended in Mar. 2026 was -80.32%. Compass Pathways's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 11,803.45%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Compass Pathways's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -12.76%.

Compass Pathways  (MEX:CMPSN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Compass Pathways's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-2916.032 * ( 1 - 0% )/( (4469.411 + 2791.607)/ 2 )
=-2916.032/3630.509
=-80.32 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3787.481 - 331.881 - ( 2693.797 - max(0, 4461.722 - 3447.911+2693.797))
=4469.411

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9588.69 - 358.147 - ( 8403.419 - max(0, 2773.375 - 9212.311+8403.419))
=2791.607

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Compass Pathways's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=6683.352/( ( (61.652 + max(-3631.156, 0)) + (51.592 + max(-2200.279, 0)) )/ 2 )
=6683.352/( ( 61.652 + 51.592 )/ 2 )
=6683.352/56.622
=11,803.45 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 477.06) - (331.881 + 0 + 3776.335)
=-3631.156

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 536.057) - (358.147 + 0 + 2378.189)
=-2200.279

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Compass Pathways's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-3257.359/25534.000
=-12.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Compass Pathways EBIT Related Terms

Compass Pathways EBIT Historical Data

* Premium members only.

The historical data trend for Compass Pathways's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Compass Pathways EBIT Chart

Compass Pathways Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial -1,467.63 -1,776.03 -1,960.19 -3,108.52 -5,146.35

Compass Pathways Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -335.23 -698.85 -2,510.26 -1,719.09 1,670.84

MEX:CMPSN vs MD, SGRY, ADUS: EBIT Comparison

For the Medical Care Facilities subindustry, Compass Pathways's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Compass Pathways EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Compass Pathways's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Compass Pathways's EV-to-EBIT falls into.


MEX:CMPSN
14GF Score
Compass Pathways PLC MEX:CMPSN
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compass Pathways EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-3,257.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of MXN-3,257.36 Mil mean?
Compass Pathways (MEX:CMPSN) has a EBIT of MXN-3,257.36 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Compass Pathways.
Is Compass Pathways' EBIT too high?
Compass Pathways' current EBIT is MXN-3,257.36 Mil. Overall, Compass Pathways has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Compass Pathways' EBIT compare to MD and SGRY?
Compass Pathways' EBIT of MXN-3,257.36 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Compass Pathways. Compass Pathways's current EBIT is MXN-3,257.36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compass Pathways stock overvalued right now?
Compass Pathways (MEX:CMPSN) has a current EBIT of MXN-3,257.36 Mil. The current EBIT is MXN-3,257.36 Mil. Compass Pathways' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Compass Pathways (MEX:CMPSN), the current EBIT is MXN-3,257.36 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Compass Pathways Business Description

Other Exchanges CMPS:USA5Y6:Germany
Address 33 Broadwick Street, London, GBR, W1F 0DQ
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
14GF Score

Get the complete analysis for MEX:CMPSN

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN242.00
Price